联合建模动态预测临床高危精神病青少年的结局
基于北美前驱期纵向研究第三波(NAPLS 3)488名12至30岁精神病风险综合征患者,采用联合建模框架预测精神病转化和症状缓解,并与基线模型比较。联合模型预测转化的平衡准确率为0.91、缓解为0.99,显著优于基线模型(转化0.65、缓解0.60),且个体内两结局风险呈更强负相关(r=-0.92,P<.001)。
要点
- 联合模型预测精神病转化的平衡准确率为0.91,显著优于基线模型的0.65。
- 联合模型预测症状缓解的平衡准确率为0.99,显著优于基线模型的0.60。
- 监测2个月内临床症状与功能的短期变化有助于解析异质性动态轨迹。
核心结论
- 联合模型在预测精神病转化和症状缓解方面均显著优于基线模型,提示监测短期临床变化有助于解析临床高危精神病人群的异质性动态临床轨迹。
研究设计与样本
- 数据来自北美前驱期纵向研究第三波(NAPLS 3),为9个中心的前瞻性纵向研究。
- 纳入488名12至30岁符合精神病风险综合征标准的个体,基线及2个月起至24个月多次随访收集临床、神经认知和人口学变量。
- 采用联合建模框架估计最终结局概率,并在10折交叉验证框架中开发与测试模型。
主要发现
- 488名参与者中232名(47.5%)为女性,平均(SD)年龄为18.2(3.4)岁。
- 联合模型预测转化的平衡准确率为0.91,基线模型为0.65;预测缓解的平衡准确率为0.99,基线模型为0.60。
- 识别出在2个月跨度内结局组间呈现差异变化的临床变量,包括症状严重程度和功能方面的测量。
- 使用联合模型时个体内两结局风险负相关更强(r=-0.92;P<.001),基线模型为r=-0.50;P<.001。
关键数值与推荐
- 转化标准:阳性症状达到完全精神病性范围。
- 症状缓解标准:在精神病风险综合征量表上处于前驱期以下水平持续6个月或以上。
临床怎么用
- 联合模型可基于短期临床变化动态预测精神病转化与症状缓解,可能帮助解析临床高危人群的异质性轨迹。
- 研究结果可为靶向治疗选择研究提供参考,并推动预测模型向临床实施靠近。
局限性
- 原文摘要未报告模型外部验证结果。
- 原文摘要未报告联合模型在临床实施中的具体障碍或校准度指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Leveraging the dynamic nature of clinical variables in the clinical high risk for psychosis (CHR-P) population has the potential to significantly improve the performance of outcome prediction models. OBJECTIVE: To improve performance of prediction models and elucidate dynamic clinical profiles using joint modeling to predict conversion to psychosis and symptom remission. DESIGN, SETTING, AND PARTICIPANTS: Data were collected as part of the third wave of the North American Prodrome Longitudinal Study (NAPLS 3), which is a 9-site prospective longitudinal study. Participants were individuals aged 12 to 30 years who met criteria for a psychosis-risk syndrome. Clinical, neurocognitive, and demographic variables were collected at baseline and at multiple follow-up visits, beginning at 2 months and up to 24 months. An initial feature selection process identified longitudinal clinical variables that showed differential change for each outcome group across 2 months. With these variables, a joint modeling framework was used to estimate the likelihood of eventual outcomes. Models were developed and tested in a 10-fold cross-validation framework. Clinical data were collected between February 2015 and November 2018, and data were analyzed from February 2022 to December 2023. MAIN OUTCOMES AND MEASURES: Prediction models were built to predict conversion to psychosis and symptom remission. Participants met criteria for conversion if their positive symptoms reached the fully psychotic range and for symptom remission if they were subprodromal on the Scale of Psychosis-Risk Symptoms for a duration of 6 months or more. RESULTS: Of 488 included NAPLS 3 participants, 232 (47.5%) were female, and the mean (SD) age was 18.2 (3.4) years. Joint models achieved a high level of accuracy in predicting conversion (balanced accuracy [BAC], 0.91) and remission (BAC, 0.99) compared with baseline models (conversion: BAC, 0.65; remission: BAC, 0.60). Clinical variables that showed differential change between outcome groups across a 2-month span, including measures of symptom severity and aspects of functioning, were also identified. Further, intra-individual risks for each outcome were more negatively correlated when using joint models (r = -0.92; P < .001) compared with baseline models (r = -0.50; P < .001). CONCLUSIONS AND RELEVANCE: In this study, joint models significantly outperformed baseline models in predicting both conversion and remission, demonstrating that monitoring short-term clinical change may help to parse heterogeneous dynamic clinical trajectories in a CHR-P population. These findings could inform additional study of targeted treatment selection and could move the field closer to clinical implementation of prediction models.
引用
- Worthington MA, Addington J, Bearden CE, et al. Dynamic Prediction of Outcomes for Youth at Clinical High Risk for Psychosis: A Joint Modeling Approach. JAMA Psychiatry. 2023. PMID: 37531131. doi:10.1001/jamapsychiatry.2023.2378
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。